This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Welsch, C. W. Search for Related Content PubMed PubMed Citation Articles by Welsch, C. W.

Host Factors Affecting the Growth of Carcinogen-induced Rat Mammary Carcinomas: A Review and Tribute to Charles Brenton Huggins

Department of Anatomy, Michigan State University, East Lansing, Michigan 48824

The carcinogen-induced rat mammary carcinoma model, developed a quarter of a century ago by Dr. Charles Brenton Huggins, is today the standard laboratory animal model in the study of human breast cancer. This model has a number of features that make it particularly attractive to the experimental oncologist, e.g., tumor induction ease and reliability, organ site specificity, tumors of ductal origin, tumors of predominantly carcinomatous histopathological characteristics, tumors of varying growth factor and/or hormone responsiveness, and the potential to examine tumor initiation and promotion processes. Since the development of this model, an extensive literature describing the biological behavior and responsiveness of these tumors has been provided. The purpose of this communication is to condense, summarize, and integrate this vast literature into a single review with the intent on facilitating information acquisition and conceptualism by both the new and the established experimental oncologist. In addition, and equally important, this communication is a tribute to Dr. Huggins, whose pioneering efforts in the development of this model and whose scientific contributions and dedication to the oncological sciences in general have made an important and lasting impact on us all.

¹ To whom requests for reprints should be addressed.

Received 12/ 3/84. Revised 3/11/85. Accepted 4/12/85.

This article has been cited by other articles:

				Y. M. Coyle, X.-J. Xie, C. M. Lewis, D. Bu, S. Milchgrub, and D. M. Euhus Role of Physical Activity in Modulating Breast Cancer Risk as Defined by APC and RASSF1A Promoter Hypermethylation in Nonmalignant Breast Tissue Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 192 - 196. [Abstract] [Full Text] [PDF]

				M. G. Manjanatha, S. Shelton, M. E. Bishop, L. E. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue(R) transgenic rats. Carcinogenesis, December 1, 2006; 27(12): 2555 - 2564. [Abstract] [Full Text] [PDF]

				M. Manjanatha, S. Shelton, M. Bishop, L. Lyn-Cook, and A. Aidoo Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats Carcinogenesis, October 1, 2006; 27(10): 1970 - 1979. [Abstract] [Full Text] [PDF]

				C. Qiu, L. Shan, M. Yu, and E. G. Snyderwine Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, April 1, 2005; 26(4): 763 - 769. [Abstract] [Full Text] [PDF]

				S. Lee, M. Simpson, M. Nimmo, and Z. Xu Low zinc intake suppressed N-methyl-N-nitrosourea-induced mammary tumorigenesis in Sprague-Dawley rats Carcinogenesis, October 1, 2004; 25(10): 1879 - 1885. [Abstract] [Full Text] [PDF]

				J. Hoffmann, R. Bohlmann, N. Heinrich, H. Hofmeister, J. Kroll, H. Kunzer, R. B. Lichtner, Y. Nishino, K. Parczyk, G. Sauer, et al. Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer J Natl Cancer Inst, February 4, 2004; 96(3): 210 - 218. [Abstract] [Full Text] [PDF]

				Y. Guan, N. M. Rubenstein, K. L. Failor, P. L. Woo, and G. L. Firestone Glucocorticoids Control {beta}-Catenin Protein Expression and Localization through Distinct Pathways that Can Be Uncoupled by Disruption of Signaling Events Required for Tight Junction Formation in Rat Mammary Epithelial Tumor Cells Mol. Endocrinol., January 1, 2004; 18(1): 214 - 227. [Abstract] [Full Text] [PDF]

				A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]

				T. J. Abrams, L. J. Murray, E. Pesenti, V. Walker Holway, T. Colombo, L. B. Lee, J. M. Cherrington, and N. K. Pryer Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer Mol. Cancer Ther., October 1, 2003; 2(10): 1011 - 1021. [Abstract] [Full Text]

				F. J. Esteva, J. Glaspy, S. Baidas, L. Laufman, L. Hutchins, M. Dickler, D. Tripathy, R. Cohen, A. DeMichele, R. C. Yocum, et al. Multicenter Phase II Study of Oral Bexarotene for Patients With Metastatic Breast Cancer J. Clin. Oncol., March 15, 2003; 21(6): 999 - 1006. [Abstract] [Full Text] [PDF]

				K.-U. Wagner, C. A. Boulanger, M. D. Henry, M. Sgagias, L. Hennighausen, and G. H. Smith An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal Development, March 5, 2003; 129(6): 1377 - 1386. [Abstract] [Full Text] [PDF]

				C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler The Role of Prolactin in Mammary Carcinoma Endocr. Rev., February 1, 2003; 24(1): 1 - 27. [Abstract] [Full Text] [PDF]

				B. S. Han, K. Fukamachi, N. Takasuka, T. Ohnishi, M. Maeda, T. Yamasaki, and H. Tsuda Inhibitory effects of 17{beta}-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats Carcinogenesis, July 1, 2002; 23(7): 1209 - 1215. [Abstract] [Full Text] [PDF]

				T. Kuramoto, K. Morimura, S. Yamashita, E. Okochi, N. Watanabe, T. Ohta, M. Ohki, S. Fukushima, T. Sugimura, and T. Ushijima Etiology-specific Gene Expression Profiles in Rat Mammary Carcinomas Cancer Res., July 1, 2002; 62(13): 3592 - 3597. [Abstract] [Full Text] [PDF]

				Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF]

				G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF]

				H. Huynh, C. Y. Ng, C. K. Ong, K. B. Lim, and T. W. M. Chan Cloning and Characterization of a Novel Pregnancy-Induced Growth Inhibitor in Mammary Gland Endocrinology, August 1, 2001; 142(8): 3607 - 3615. [Abstract] [Full Text] [PDF]

				G. Thordarson, K. Van Horn, R. C. Guzman, S. Nandi, and F. Talamantes Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones Carcinogenesis, July 1, 2001; 22(7): 1027 - 1033. [Abstract] [Full Text] [PDF]

				D. Marcantonio, L. E. Chalifour, M. A. Alaoui-Jamali, L. Alpert, and H. T. Huynh Cloning and Characterization of a Novel Gene That Is Regulated by Estrogen and Is Associated with Mammary Gland Carcinogenesis Endocrinology, June 1, 2001; 142(6): 2409 - 2418. [Abstract] [Full Text] [PDF]

				C. J. Grill, W. S. Cohick, and A. R. Sherman Postpubertal Development of the Rat Mammary Gland Is Preserved during Iron Deficiency J. Nutr., May 1, 2001; 131(5): 1444 - 1448. [Abstract] [Full Text]

				G. Perletti, P. Concari, R. Giardini, E. Marras, F. Piccinini, J. Folkman, and L. Chen Antitumor Activity of Endostatin against Carcinogen-induced Rat Primary Mammary Tumors Cancer Res., April 1, 2000; 60(7): 1793 - 1796. [Abstract] [Full Text]

				J. P. Lydon, G. Ge, F. S. Kittrell, D. Medina, and B. W. O'Malley Murine Mammary Gland Carcinogenesis Is Critically Dependent on Progesterone Receptor Function Cancer Res., September 1, 1999; 59(17): 4276 - 4284. [Abstract] [Full Text] [PDF]

				R. C. Guzman, J. Yang, L. Rajkumar, G. Thordarson, X. Chen, and S. Nandi Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy PNAS, March 2, 1999; 96(5): 2520 - 2525. [Abstract] [Full Text] [PDF]

				I. Leav, F. B. Merk, K. F. Lee, M. Loda, M. Mandoki, J. E. McNeal, and S.-m. Ho Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions Am. J. Pathol., March 1, 1999; 154(3): 863 - 870. [Abstract] [Full Text] [PDF]

				J. E. Korkola and M. C. Archer Resistance to mammary tumorigenesis in Copenhagen rats is associated with the loss of preneoplastic lesions Carcinogenesis, February 1, 1999; 20(2): 221 - 227. [Abstract] [Full Text] [PDF]

				J. I. Macgregor and V. C. Jordan Basic Guide to the Mechanisms of Antiestrogen Action Pharmacol. Rev., June 1, 1998; 50(2): 151 - 196. [Abstract] [Full Text] [PDF]

				C. J. Ormandy, R. E. Hall, D. L. Manning, J. F. R. Robertson, R. W. Blamey, P. A. Kelly, R. I. Nicholson, and R. L. Sutherland Coexpression and Cross-Regulation of the Prolactin Receptor and Sex Steroid Hormone Receptors in Breast Cancer J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3692 - 3699. [Abstract] [Full Text] [PDF]

				T. K. Said, O. M. Conneely, D. Medina, B. W. O'Malley, and J. P. Lydon Progesterone, in Addition to Estrogen, Induces Cyclin D1 Expression in the Murine Mammary Epithelial Cell, in Vivo Endocrinology, September 1, 1997; 138(9): 3933 - 3939. [Abstract] [Full Text] [PDF]

				S. K. Clinton Diet, Anthropometry and Breast Cancer: Integration of Experimental and Epidemiologic Approaches J. Nutr., May 1, 1997; 127 (5): 916S - 916S. [Abstract] [Full Text] [PDF]

				P. Buse, P. L. Woo, D. B. Alexander, A. Reza, and G. L. Firestone Glucocorticoid-induced Functional Polarity of Growth Factor Responsiveness Regulates Tight Junction Dynamics in Transformed Mammary Epithelial Tumor Cells J. Biol. Chem., November 24, 1995; 270(47): 28223 - 28227. [Abstract] [Full Text] [PDF]

				J P Lydon, F J DeMayo, C R Funk, S K Mani, A R Hughes, C A Montgomery, G Shyamala, O M Conneely, and B W O'Malley Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes & Dev., September 15, 1995; 9(18): 2266 - 2278. [Abstract] [PDF]

				P. Buse, P. L. Woo, D. B. Alexander, H. H. Cha, A. Reza, N. D. Sirota, and G. L. Firestone Transforming Growth Factor-alpha Abrogates Glucocorticoid-stimulated Tight Junction Formation and Growth Suppression in Rat Mammary Epithelial Tumor Cells J. Biol. Chem., March 24, 1995; 270(12): 6505 - 6514. [Abstract] [Full Text] [PDF]

				R. J. Nelson and J. M. C. Blom Photoperiodic Effects on Tumor Development and Immune Function J Biol Rhythms, December 1, 1994; 9(3-4): 233 - 249. [Abstract] [PDF]

				R Kumar, S Sukumar, and M Barbacid Activation of ras oncogenes preceding the onset of neoplasia Science, June 1, 1990; 248(4959): 1101 - 1104. [Abstract] [PDF]

				S Sukumar, W. Carney, and M Barbacid Independent molecular pathways in initiation and loss of hormone responsiveness of breast carcinomas Science, April 22, 1988; 240(4851): 524 - 526. [Abstract] [PDF]

				P. Hinkle and P. Kinsella Thyroid hormone induction of an autocrine growth factor secreted by pituitary tumor cells Science, December 19, 1986; 234(4783): 1549 - 1552. [Abstract] [PDF]